Gruber Helen E, Hoelscher Gretchen L, Ingram Jane A, Bethea Synthia, Hanley Edward N
Department of Orthopaedic Surgery, Carolinas Medical Center, PO Box 32861, Charlotte, NC 28232, USA.
Growth Factors. 2008 Aug;26(4):220-5. doi: 10.1080/08977190802273814.
The aging human intervertebral disc contains a sizeable population of senescent cells. Since senescent cells cannot divide, senescence reduces the disc's ability to generate new cells to replace existing ones lost to necrosis or apoptosis. The objectives of the present work were: (1) to develop a reliable in vitro model for stress-induced premature senescence in human annulus cells, and (2) to investigate the potential for insulin-like growth factor-1 (IGF-1) to prevent or ameliorate senescence in vitro. The developed experimental model employs a 2 h exposure to 50 microM hydrogen peroxide; immunocytochemical localization of senescence associated-beta-galactosidase at pH 6.0 was used as the marker for senescent cells, and the percentage of senescent cells quantified after 3 days of culture. Nine sets of annulus cells were obtained from eight human surgical disc specimens; cells were tested with 0, 50, 100 or 500 ng/ml IGF-1. Although 50 or 100 ng/ml IGF-1 did not significantly alter the percentage of senescent cells, a significant reduction was present following exposure to 500 ng/ml IGF-1 (control, 56.3% +/- 8.5 (9); mean +/- SEM, (n) vs. treated, 39.6% +/- 6.6 (9), p = 0.0009). These novel findings point to the value of continued research towards development of future biologic therapies designed to reduce cell senescence in degenerating human discs.
衰老的人类椎间盘含有大量衰老细胞。由于衰老细胞无法分裂,细胞衰老会降低椎间盘产生新细胞以替代因坏死或凋亡而损失的现有细胞的能力。本研究的目的是:(1)建立一种可靠的体外模型,用于诱导人椎间盘纤维环细胞应激性早衰;(2)研究胰岛素样生长因子-1(IGF-1)在体外预防或改善细胞衰老的潜力。所建立的实验模型采用将细胞暴露于50微摩尔过氧化氢中2小时;以pH 6.0时衰老相关β-半乳糖苷酶的免疫细胞化学定位作为衰老细胞的标志物,并在培养3天后对衰老细胞的百分比进行定量。从8个人类手术椎间盘标本中获取了9组纤维环细胞;用0、50、100或500纳克/毫升的IGF-1对细胞进行测试。虽然50或100纳克/毫升的IGF-1没有显著改变衰老细胞的百分比,但在暴露于500纳克/毫升的IGF-1后,衰老细胞百分比显著降低(对照组,56.3%±8.5(9);平均值±标准误,(n)与处理组,39.6%±6.6(9),p = 0.0009)。这些新发现表明,继续开展研究以开发未来旨在减少退变人椎间盘细胞衰老的生物疗法具有重要价值。